Table 5. Multivariate models of prognostic factors among subset of women who received surgery alone (n=3,407).
Factors | aHR* of overall survival (95% CI) | p-value | |
---|---|---|---|
Age (yr) | |||
≤40 | Reference | ||
≤50 | 0.978 (0.628–1.522) | 0.920 | |
≤60 | 1.368 (0.878–2.129) | 0.166 | |
≤70 | 0.807 (0.440–1.483) | 0.490 | |
>70 | 3.116 (1.836–5.289) | <0.001 | |
T categories | |||
T1B | Reference | ||
T2 | 3.074 (2.089–4.522) | <0.001 | |
N categories | |||
N0 | Reference | ||
N1 | 4.170 (2.569–6.767) | <0.001 | |
M categories | |||
M0 | Reference | ||
M1 | 3.825 (1.203–12.456) | <0.001 | |
Histology | |||
SCC | Reference | ||
Adenocarcinoma | 1.997 (1.401–2.849) | <0.001 | |
Others | 3.076 (1.957–4.846) | <0.001 | |
Institutions | |||
Non-JSGO-accredited | Reference | ||
JSGO-accredited | 0.552 (0.393–0.775) | 0.004 |
aHR, adjusted-hazard ratio; CI, confidence interval; HR, hazard ratio; JSGO, Japan Society of Gynecologic Oncology; M, metastasis; N, node; SCC, squamous cell carcinoma; T, tumor.
*HRs are adjusted for all variables in the table.